F Star Therapeutics Inc Revenue per Employee (FSTX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
F star Therapeutics Inc   (NASDAQ: FSTX)
 

F Star Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 49.8% in the third quarter 2022, year on year to cumulative value of $21 million, F Star Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 378,125. The productivity of F Star Therapeutics Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector F star Therapeutics Inc achieved the highest revenue per employee. While revenue per employee remained unchanged compared to the previous quarter at no. .F Star Therapeutics Inc has 56 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FSTX Revenue per Employee (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Revenue Change 49.8 % - -12.55 % 10635.58 % -91.83 %
Sales per Employee (TTM) $ 378,125 371,446 371,446 377,982 68,411
FSTX's Total Ranking # # # # #
Seq. Revenue Change - - -85.42 % 2230.09 % -

FSTX Company Profile >> Back to FSTX Efficiency Comparisons >> Compare FSTX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 228,893 $ 214,946 $ 201,000
(Mar 31 2021)   (Dec 31 2020)



Financial Statements
F Star Therapeutics Inc 's Revenue MRQ $ 1 Millions Visit FSTX's Income Statement
F Star Therapeutics Inc 's Revenues TTM $ 21 Millions Visit FSTX's aggregate revenue growth
What are FSTX's Sales? Visit FSTX's Sales by Segment




Other Ratios
F Star Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
FSTX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for FSTX's Competitors
Revenue per Employee for FSTX's Suppliers
Revenue per Employee for FSTX's Customers

You may also want to know
FSTX's Sales Growth Rates FSTX's Pe Price to earnings ratio FSTX's Receivables Turnover Ratio FSTX's Stock Quote
FSTX's Net Income Growth Rates FSTX's Ps Price to Sales ratio FSTX's Sales per Employee FSTX's Asset Turnover Ratio
FSTX's Net Margin FSTX's Pb Price to Book ratio FSTX's Financial Strength Ratios FSTX's Dividend Payout Ratio
Date modified: 2026-09-18T13:11:05+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2022Number of Employees Sep 30 2022
Orasure Technologies Inc  655,938.00 $ 327.969  Million 500 
Skinhealth Systems Inc   641,254.24 $ 393.089  Million 613 
Acadia Pharmaceuticals Inc   640,981.20 $ 511.503  Million 798 
Neptune Wellness Solutions Inc   640,694.75 $ 54.459  Million 85 
Healthlynked Corp  636,104.10 $ 6.361  Million 10 
Amicus Therapeutics inc   632,663.41 $ 323.291  Million 511 
Ati Physical Therapy Inc   629,670.00 $ 629.670  Million 1,000 
Organon and Co   629,200.00 $ 6,292.000  Million 10,000 
Milestone Scientific Inc   627,400.13 $ 9.411  Million 15 
Reshape Lifesciences Inc  626,222.22 $ 11.272  Million 18 
Ionis Pharmaceuticals Inc   624,452.92 $ 875.483  Million 1,402 
Biomarin Pharmaceutical Inc  623,505.43 $ 2,008.311  Million 3,221 
Embecta Corp   610,540.54 $ 1,129.500  Million 1,850 
Iridex Corp  601,698.92 $ 55.958  Million 93 
Fulgent Genetics Inc   597,421.88 $ 802.935  Million 1,344 
Bionexus Gene Lab Corp   596,547.53 $ 11.334  Million 19 
Lftd Partners Inc   588,902.22 $ 58.890  Million 100 
Caremax Inc   585,175.00 $ 585.175  Million 1,000 
Eli Lilly And Company  584,790.00 $ 29,239.500  Million 50,000 
Cutera Inc   582,965.12 $ 250.675  Million 430 
Ngm Biopharmaceuticals Inc   581,110.00 $ 58.111  Million 100 
3m Company  574,578.51 $ 34,762.000  Million 60,500 
Theravance Biopharma inc   573,811.11 $ 51.643  Million 90 
Luna Innovations Inc  567,150.00 $ 90.744  Million 160 
Molecular Templates Inc   566,241.94 $ 35.107  Million 62 
Avantor Inc   564,814.81 $ 7,625.000  Million 13,500 
Sigilon Therapeutics Inc   558,636.36 $ 12.290  Million 22 
Viatris Inc   557,610.00 $ 16,728.300  Million 30,000 
Zoetis Inc   552,206.90 $ 8,007.000  Million 14,500 
Alkermes Plc   551,992.20 $ 1,131.584  Million 2,050 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.